Trump Cuts Prices on Ozempic and Wegovy in Deal With GLP-1 Weight Loss Drug Makers
President Trump announced a deal with Eli Lilly and Novo Nordisk to significantly reduce the prices of GLP-1 medications, including Ozempic and Wegovy. Under the new pricing, monthly costs can drop to about $250, with future drugs priced at a capped rate of $149. This initiative is part of a